EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Lung Cancer—Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature)

Beata Smolarz iD, Honorata Łukasiewicz, Dariusz Samulak, Ewa Piekarska, Radosław Kołaciński, Hanna Romanowicz

International Journal of Molecular Sciences · 26.02.2025 · 26 (5) · 2049

DOI: 10.3390/ijms26052049 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.02.2025. Verfasst von Beata Smolarz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cancer Genetics, Department of Pathology, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit wurde bisher 304-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lung cancer is one of the most common malignant cancers in most countries and is the leading cause of death among cancer diseases worldwide. Despite constant progress in diagnosis and therapy, survival rates of patients diagnosed with lung cancer remain unsatisfactory. Numerous epidemiological and experimental studies conducted as early as the 1970s confirm that the most important risk factor for the development of lung cancer is long-term smoking, which remains valid to this day. In the paper, the authors present the latest data on the epidemiology, pathogenesis, treatment and molecular aspects of this cancer. In the last decade, many molecular alterations that are effective in the development of lung cancer have been discovered. In adenocarcinoma, tyrosine kinase inhibitors were developed for EGFR mutations and ALK and ROS1 translocations and were approved for use in the treatment of advanced stage adenocarcinomas. In the case of squamous cell carcinoma, the evaluation of these mutations is not yet being used in clinical practice. In addition, there are ongoing studies concerning many potential therapeutic molecular targets, such as ROS, MET, FGFR, DDR-2 and RET. Constant progress in diagnostic and therapeutic methods gives rise to hopes for an improved prognosis in patients with lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsHumansMutationErbB ReceptorsProtein Kinase InhibitorsMolecular Targeted Therapy

Stichwörter der Autor:innen

geneticslung cancerpathogenesistreatment

Substanzen

ErbB ReceptorsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Laboratory of Cancer Genetics, Department of Pathology, Polish Mother's Memorial Hospital Research Institute, 93-338 Lodz, Poland.
  • Faculty of Medicine and Health Sciences, Department of Nursing, The President Stanisław Wojciechowski Calisia University, 62-800 Kalisz, Poland.
  • Department of Obstetrics and Gynecology and Gynecological Oncology, Regional Hospital in Kalisz, 62-800 Kalisz, Poland.
  • Department of Obstetrics, The President Stanisław Wojciechowski Calisia University, 62-800 Kalisz, Poland.
  • Regional Hospital in Kalisz, 62-800 Kalisz, Poland.

ORCID-Profile: Beata Smolarz

Zitieren

APA

Smolarz, B., Łukasiewicz, H., Samulak, D., Piekarska, E., Kołaciński, R., & Romanowicz, H. (2025). Lung Cancer—Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature). International Journal of Molecular Sciences, 26(5), 2049. https://doi.org/10.3390/ijms26052049

Vancouver

Smolarz B, Łukasiewicz H, Samulak D, Piekarska E, Kołaciński R, Romanowicz H. Lung Cancer—Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature). International Journal of Molecular Sciences. 2025;26(5):2049. doi:10.3390/ijms26052049

BibTeX
@article{Smolarz2025,
  author = {Smolarz, Beata and Łukasiewicz, Honorata and Samulak, Dariusz and Piekarska, Ewa and Kołaciński, Radosław and Romanowicz, Hanna},
  title = {Lung Cancer—Epidemiology, Pathogenesis, Treatment and Molecular Aspect (Review of Literature)},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {5},
  pages = {2049},
  doi = {10.3390/ijms26052049}
}
Kostenlos starten →